Results 211 to 220 of about 935,385 (269)

Safety and efficacy of a feed additive consisting of endo-1,4-beta-xylanase produced with <i>Bacillus subtilis</i>LMG S-15136 (Belfeed B MP/ML) (4a1606i) for all poultry species, suckling and weaned piglets, pigs for fattening, lactating sows and all minor porcine species other than reproductive animals for the renewal of its authorisation and the extension of its use to all <i>Suidae</i> (Puratos NV). [PDF]

EFSA J
EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), Villa RE, Azimonti G, Bonos E, Christensen H, Durjava M, Dusemund B, Gehring R, Glandorf B, Kouba M, López-Alonso M, Marcon F, Nebbia C, Pechová A, Prieto-Maradona M, Theodoridou K, Mayo B, Anguita M, Innocenti ML, Bozzi Cionci N, Brozzi R, Kolona M, Tarrés-Call J.   +22 more
europepmc   +1 more source

Use of a Molecular Signature Response Classifier to Inform Treatment Selection Improves Clinical Disease Activity Among Patients with Rheumatoid Arthritis Initiating a Biologic or Targeted Synthetic Disease‐Modifying Antirheumatic Drug

Arthritis Care &Research, EarlyView.
Objective We assessed the effectiveness of PrismRA to improve clinical outcomes among patients with rheumatoid arthritis (RA) initiating treatment with a biologic or targeted synthetic disease‐modifying antirheumatic drug (b/tsDMARD). Methods PrismRA incorporated 19 gene expression features and four clinical features to assess a patient's likelihood of
Fenglong Xie, Timothy Beukelman, Nicholas P. McCormick, Jeffrey R. Curtis   +3 more
wiley   +1 more source

Mapping the social networks of key actors in the development of health technology assessment in Iran. [PDF]

J Prev Med Hyg
Behzadifar M, Shahabi S, Bakhtiari A, Azari S, Teli BD, Yarahmadi M, Martini M, Behzadifar M.   +7 more
europepmc   +1 more source

From fear of infection to awareness against stigma: A mixed-methods analysis of discourses on HIV in a parliamentary context. [PDF]

PLoS One
Gonzalez-Recio P, Barba-Sánchez R, Granda É, Guerras JM, Moreno-García S, Iglesias A, Fuster-RuizdeApodaca MJ, García Expósito E, Palma D, Belza MJ.   +9 more
europepmc   +1 more source

Rheumatologic Manifestations of Patients With Type B Insulin Resistance

Arthritis Care &Research, EarlyView.
Objective The objectives of this study were to identify laboratory and clinical features associated with type B insulin resistance (TBIR), a rare condition caused by autoantibodies that inhibit the insulin receptor, most frequently occurring in the setting of systemic lupus erythematosus (SLE), and to increase awareness of this rare, life‐threatening ...
S. Amara Ogbonnaya, Sandra G. Williams, Raphael A. Kirou, Marissa Lightbourne, Rebecca J. Brown   +4 more
wiley   +1 more source

Assessment of genetically modified soybean MON 87769 for renewal authorisation under Regulation (EC) No 1829/2003 (dossier GMFF-2023-21253). [PDF]

EFSA J
EFSA Panel on Genetically Modified Organisms (GMO), Casacuberta J, Barro F, Braeuning A, de Maagd R, Epstein MM, Frenzel T, Gallois JL, Koning F, Messéan A, Moreno FJ, Nogué F, Savoini G, Schulman AH, Tebbe C, Veromann E, Gómez JÁ, Goumperis T, Lenzi P, Camargo AM, Piffanelli P, Raffaello T, Gonzales ABG, Sánchez-Brunete E.   +23 more
europepmc   +1 more source

Minimal important change and minimal clinically important difference in pain and function with exercise in hip osteoarthritis

Arthritis Care &Research, Accepted Article.
Objective The objective of this study was to estimate the minimal important change (MIC) and minimal clinically important difference (MCID) for pain and physical function in individuals with hip osteoarthritis (OA) following a physiotherapist‐guided exercise intervention.
Yareni Guerrero, Fiona Dobson, Venkatesha Venkatesha, Kim Allison, Gabrielle Knox, Libby Spiers, Travis Haber, David J Hunter, Michelle Hall   +8 more
wiley   +1 more source

The health sector - led campaign to realise Australia's national Strategy on health and climate change. [PDF]

J Clim Chang Health
Armstrong F.
europepmc   +1 more source

Formal and informal social care in people with Rheumatic and Musculoskeletal diseases: a cross‐sectional multicentre survey

Arthritis Care &Research, Accepted Article.
Introduction Rheumatic and musculoskeletal diseases(RMDs) are leading causes of physical disability, necessitating support with activities of daily living(ADLs). This study describes social care received by patients with RMDs in two disperate regions of England: Salford(urban) and Norfolk(rural).
Mehreen Somro, Karen Durrant, William G Dixon, John McBeth, Alex MacGregor, Max Yates, Jenny H Humphreys   +6 more
wiley   +1 more source

Assessment of genetically modified maize NK603 × T25 for renewal authorisation under Regulation (EC) No 1829/2003 (dossier GMFF-2023-21252). [PDF]

EFSA J
EFSA Panel on Genetically Modified Organisms (GMO), Casacuberta J, Barro F, Braeuning A, de Maagd R, Epstein MM, Frenzel T, Gallois JL, Koning F, Messéan A, Moreno FJ, Nogué F, Savoini G, Schulman AH, Tebbe C, Veromann E, Lenzi P, Camargo AM, Piffanelli P, Raffaello T.   +19 more
europepmc   +1 more source